| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 13.645 | 16.187 | 24.556 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 13.645 | 16.308 | 24.635 |
| Total Expenses - EUR | - | - | - | - | - | 12 | 0 | 8.778 | 7.499 | 12.697 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -12 | 0 | 4.866 | 8.809 | 11.938 |
| Net Profit/Loss - EUR | - | - | - | - | - | -12 | 0 | 4.465 | 7.299 | 9.759 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Symphytum Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 248 | 243 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 194 | 190 | 6.189 | 9.706 | 15.195 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 812 |
| Cash | - | - | - | - | - | 194 | 190 | 6.189 | 9.706 | 14.384 |
| Shareholders Funds | - | - | - | - | - | 29 | 28 | 4.494 | 8.264 | 14.262 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 413 | 404 | 1.696 | 1.442 | 934 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Symphytum Medical S.r.l.